|
No chemo?
I also hope not to upset others, but that's precisely the info I was seeking. The onc. gave me adjuvantonline stats (42% recurrence and 30% death in 10 years) saying, these also include ER/PR+ patients treated with tamoxifen ... and include larger tumors, up to 5 cm.
Being ER/PR- and the width of a hair past Stage 1, this wasn't useful info. With much searching, I found these stats for relapse in early breast cancer, at a 2-year f/u: ER,PR-, Her2+, node negative, 18%. 1-3 nodes 25%, greater 4 nodes 33%, without Herceptin. (Also, ER/PR+, Her2+, node negative 9%, 1-3 nodes 12%, greater 4 nodes 33%, also without Herceptin.) Very little detail, and as of October 2005, these results "weren't out yet."
The oncologist estimated the benefit of adjuvant therapy, based on her non-relevant stats, to be 6% reduction in recurrence and 11% reduction in death, both at 10 years. When I asked about 5 years, she said not to try to slice numbers. In my case, sounds like less than 1% per year difference in outcome, considering my ER/PR- and Her2+++ status.
merryg
|